Target intelligence / Profile preview

Outer membrane protein C (OmpK36) (OmpC)

Target
OmpC
Molecular classification
Porin, Outer membrane protein, Beta-barrel protein, Transporter
01

Overview

Outer membrane protein C, specifically known as OmpK36 in Klebsiella pneumoniae, is a major non-specific porin that forms a trimeric beta-barrel structure in the bacterial outer membrane. It functions as a critical conduit for the passive diffusion of small hydrophilic molecules, including essential nutrients and various classes of antibiotics such as carbapenems and cephalosporins. In the context of clinical pathology, OmpK36 is a primary determinant of antibiotic susceptibility; its downregulation or structural modification is a hallmark of carbapenem-resistant Enterobacteriaceae (CRE). Mutations that constrict the porin channel or the complete loss of the protein significantly limit the intracellular concentration of drugs, often working in tandem with beta-lactamase production to confer high-level resistance. Consequently, OmpK36 is a focal point for studying bacterial permeability and developing next-generation antibiotics designed to bypass or utilize these entry ports more effectively.

Other names
OmpK36Porin OmpCOuter membrane protein K36OmpK36 porin
02

Mechanism of action

OmpK36 acts as a non-specific aqueous channel that allows the passive diffusion of hydrophilic antibiotics, such as carbapenems and cephalosporins, across the outer membrane of Klebsiella pneumoniae to reach their targets in the periplasm. Resistance is often mediated by the loss of this porin or mutations that narrow the channel pore, thereby reducing drug entry.

03

Biological functions

Passive diffusion of hydrophilic moleculesOsmoregulationNutrient uptakePermeability barrier maintenance
04

Disease associations

InfectionAntimicrobial resistanceSepsisPneumoniaUrinary tract infection
05

Safety considerations

Rapid emergence of multi-drug resistance (MDR) through porin lossSynergy with beta-lactamases (e.g., KPC) leading to high-level carbapenem resistanceReduced bacterial fitness in some porin-deficient strains
06

Interacting drugs

Ertapenem

5 more in the full profile.

07

Biomarkers

OmpK36 expression levelOmpK36 gene mutations (e.g., GD or TD insertions in loop 3)Carbapenem minimum inhibitory concentration (MIC)

Beyond the preview

Go deeper on Outer membrane protein C (OmpK36) (OmpC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Outer membrane protein C (OmpK36) (OmpC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call